Key facts
- This page summarizes Amresh Kumar's Form 3 filing for Acasti Pharma Inc. (GRCE).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 18 May 2023, 15:57.
Amresh Kumar - 08 May 2023 Form 3 Insider Report for Acasti Pharma Inc. (GRCE)
- Reporting relationship
- VP Program Management
- Issuer ticker
- GRCE
- Reported as of
- 08 May 2023
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 18 May 2023, 15:57:32 UTC
- Next SEC filing
- 18 Jul 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Amresh Kumar
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Amresh Kumar filed Form 3 for Acasti Pharma Inc. (GRCE) on 18 May 2023.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ACST
holding
Class A Common Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 66,712
- Date
- 08 May 2023
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
SEC remarks
Exhibit 24, Power of Attorney, is attached.